framycetin has been researched along with dantrolene in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bertel, O; Hellmann, G; Hohenegger, M; Klein, S; Plank, B; Suko, J; Wyskovsky, W | 1 |
| Ankarcrona, M; Cedazo-Minguez, A; Cowburn, RF; Nishimura, T; Popescu, BO | 1 |
| Ankarcrona, M; Benedikz, E; Cedazo-Minguez, A; Cowburn, RF; Nishimura, T; Popescu, BO; Winblad, B | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
4 other study(ies) available for framycetin and dantrolene
| Article | Year |
|---|---|
[Calcium channel mediated calcium release from the rabbit skeletal muscle sarcoplasmic reticulum vesicle].
Topics: Adenine Nucleotides; Animals; Caffeine; Calcium; Calcium Channels; Dantrolene; In Vitro Techniques; Muscles; Neomycin; Rabbits; Ruthenium Red; Sarcoplasmic Reticulum; Spectrophotometry | 1990 |
The presenilin 1 deltaE9 mutation gives enhanced basal phospholipase C activity and a resultant increase in intracellular calcium concentrations.
Topics: Amyloid beta-Peptides; Apoptosis; Cadherins; Calcium; Carbachol; Cell Line; Cell Membrane; Coloring Agents; Dantrolene; Endoplasmic Reticulum; Enzyme Inhibitors; Exons; Humans; Hydrolysis; Immunoblotting; Immunohistochemistry; Indoles; Macrocyclic Compounds; Membrane Proteins; Microscopy, Confocal; Muscle Relaxants, Central; Mutation; Neomycin; Oxazoles; Presenilin-1; Protein Binding; Protein Structure, Tertiary; Ruthenium Red; Ryanodine; Time Factors; Transfection; Tumor Cells, Cultured; Type C Phospholipases | 2002 |
Gamma-secretase activity of presenilin 1 regulates acetylcholine muscarinic receptor-mediated signal transduction.
Topics: Amyloid Precursor Protein Secretases; Aspartic Acid Endopeptidases; Calcium; Carbachol; Cell Line; Cell Line, Tumor; Dantrolene; DNA, Complementary; Endopeptidases; Exons; Gene Deletion; Gene Expression Regulation; Humans; Hydrolysis; Immunoblotting; Membrane Proteins; Muscle Relaxants, Central; Mutation; Neomycin; Presenilin-1; Receptors, Muscarinic; Signal Transduction; Time Factors; Transfection; Type C Phospholipases | 2004 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |